Latest filing published 27 May 2026 for Castle Biosciences INC.
Insider track record
No signal scores available.
Kim Caple: trading record in brief
Kim Caple discloses dealings in Castle Biosciences Inc to SEC (Form 4). In total, 7 filings cover trades dated from 14 July 2022 to 22 May 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 27 May 2026, the filings show an option exercise in Castle Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kim Caple
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,667 sharesCommon StockSEC:0001628280-26-038470:0
- 8,673 sharesCommon StockSEC:0001447362-25-000080:0
- 440 sharesCommon StockSEC:0001447362-24-000110:0
- 8,636 sharesCommon StockSEC:0001447362-24-000096:0
- 440 sharesCommon StockSEC:0001447362-23-000120:0
- 3,825 sharesCommon StockSEC:0001447362-23-000111:0
- 440 sharesCommon StockSEC:0001447362-22-000124:0
7 of 7 declarations
